1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
64EF11758EF223E3C00258D1E002E87FD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-cns-medical-affairs-impact-equation-measuring-tactical-value-leading-indicators
18
19
20216.73.216.60
21
22
23www.emed24.net
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Affairs Excellence

CNS Medical Affairs Impact Equation: Measuring Tactical Value Through Leading Indicators

ID: 5897


Features:

12 Info Graphics

8 Data Graphics

120+ Metrics

7 Narratives


Pages/Slides: 27


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “CNS Medical Affairs Impact Equation: Measuring Tactical Value Through Leading Indicators”

STUDY OVERVIEW

CNS Medical Affairs teams are under growing pressure to demonstrate the tactical value of their activities. As leadership expectations rise, the ability to quantify Medical’s contribution via leading indicators—such as MSL insights, evidence generation, and scientific exchange—has become critical.

The benchmark research examines which activity metrics are most effective in demonstrating value, how they align with organizational priorities, and how CNS teams refine measurement frameworks over time. It is designed for senior executives seeking actionable insights to optimize field and non-field activities, improve operational efficiency, and ensure CNS Medical Affairs delivers measurable value to patients, providers, and the business.


KEY TOPICS

  • Defining Leading Indicators of CNS Medical Impact
  • Linking Leading Indicators to Strategic Outcomes
  • Translating Activity Metrics into Measurable Value
  • Real-World Examples of CNS Tactical Impact
  • Strategic Frameworks for Performance Measurement

KEY METRICS

  • Top-rated activity metrics across CNS Medical Affairs functions
  • Leading field vs. non-field activity indicators
  • Benchmark linkage rates between activities and outcomes
  • CNS medical activities most tied to enterprise-level value
  • Mapping successful outcomes to multiple contributing activities

SAMPLE KEY FINDINGS

  • Linking Activities to Outcomes Is the New Standard: 75% of CNS Medical groups now connect at least some tactical activities to measurable external outcomes—setting a new standard for accountability and influence.
  • Leading Field Indicators: Top field activity metrics deemed either “somewhat” or “highly important” for showing medical value by a majority of CNS benchmark respondents: 1) Insights from MSL interactions, 2) scientific concepts discussed, 3) total interactions, 4) % territory engaged, and 5) F2F %. Their prominence suggests Medical Affairs should sharpen how these metrics are defined and used to reflect true medical value.

METHODOLOGY

Best Practices, LLC engaged
16 Medical Affairs executives from 12 CNS-focused biopharma companies in this benchmarking research. In-depth interviews further provide insights on how CNS Medical Affairs teams are measuring tactical value through leading indicators.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Health Care; Medical Device


Companies Profiled:
AbbVie; Alnylam Pharmaceuticals; Amgen; Azurity Pharmaceuticals; Boehringer Ingelheim; Eurofarma; Jazz Pharmaceuticals; Johnson & Johnson; Otsuka; Scholar Rock; Supernus; Takeda

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.